Xiamen Xinliyuan Industry and Trade Co., Ltd. – Trademark Portfolio

Entity Type: 16

Xiamen Xinliyuan Industry and Trade Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JETFANS. The owner is based in Haicang Dist, Xiamen.

Room 102, No. 55, Pingcheng North Road

Haicang Dist, Xiamen 361026 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JETFANS
JETFANS
Registered 2025

Trademark Classifications

Xiamen Xinliyuan Industry and Trade Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Xiamen Xinliyuan Industry and Trade Co., Ltd. have?

Xiamen Xinliyuan Industry and Trade Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xiamen Xinliyuan Industry and Trade Co., Ltd. file in?

Xiamen Xinliyuan Industry and Trade Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Xiamen Xinliyuan Industry and Trade Co., Ltd.'s most well-known trademarks?

Xiamen Xinliyuan Industry and Trade Co., Ltd.'s registered trademark portfolio includes well-known marks such as JETFANS. These are among 1 currently registered trademark in the portfolio.

What is Xiamen Xinliyuan Industry and Trade Co., Ltd.'s trademark registration success rate?

Xiamen Xinliyuan Industry and Trade Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.